Nanoparticle and other metal chelation therapeutics in Alzheimer disease.
about
Nanotechnology, nanotoxicology, and neuroscienceGadolinium-based contrast agent toxicity: a review of known and proposed mechanismsTherapeutic targets of brain insulin resistance in sporadic Alzheimer's diseaseBrain insulin resistance and deficiency as therapeutic targets in Alzheimer's diseaseIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesMolecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics.Nanoparticle and iron chelators as a potential novel Alzheimer therapy.Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment.HFE gene variants, iron, and lipids: a novel connection in Alzheimer's diseaseNanoparticle delivery of transition-metal chelators to the brain: Oxidative stress will never see it coming!Antioxidant therapy in Alzheimer's disease: theory and practice.Selective removal of copper(II) from natural waters by nanoporous sorbents functionalized with chelating diamines.Challenges associated with metal chelation therapy in Alzheimer's diseaseExploring the influence of carbon nanoparticles on the formation of β-sheet-rich oligomers of IAPP₂₂₋₂₈ peptide by molecular dynamics simulation.The correlation of hippocampal T2-mapping with neuropsychology test in patients with Alzheimer's disease.A biological perspective toward the interaction of theranostic nanoparticles with the bloodstream - what needs to be considered?Paradigm shift in treatment of Alzheimer's disease: zinc therapy now a conscientious choice for care of individual patients.Lack of association between autism and four heavy metal regulatory genes.Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: implications for drug therapy.Nanoparticle-chelator conjugates as inhibitors of amyloid-beta aggregation and neurotoxicity: a novel therapeutic approach for Alzheimer diseaseChelation therapy for neurodegenerative diseases.Metal chelators coupled with nanoparticles as potential therapeutic agents for Alzheimer's diseaseMetal ion physiopathology in neurodegenerative disorders.Novel drug targets based on metallobiology of Alzheimer's disease.Nanotherapeutics for Alzheimer's disease (AD): Past, present and future.The role of iron as a mediator of oxidative stress in Alzheimer disease.Metallostasis and amyloid β-degrading enzymes.Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases.Intranasal therapeutic strategies for management of Alzheimer's disease.Nanotherapeutic strategies for the treatment of Alzheimer's disease.Hippocampal neuronal metal ion imbalance related oxidative stress in a rat model of chronic aluminum exposure and neuroprotection of meloxicam.Mesoporous silica nanoparticle-based H2O2 responsive controlled-release system used for Alzheimer's disease treatment.Progress in the development of new drugs in Alzheimer's disease.Formulation and evaluation of a salted-out isoniazid-loaded nanosystem.Inhibition of a Zn(II)-containing enzyme, alcohol dehydrogenase, by anticancer antibiotics, mithramycin and chromomycin A3.Hypothesis: apo-lactoferrin-Galantamine Proteo-alkaloid Conjugate for Alzheimer's disease Intervention.Deposition of iron and beta-amyloid plaques is associated with cortical cellular damage in rabbits fed with long-term cholesterol-enriched diets.Different particulate systems--bypass the biological barriers?Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery.
P2860
Q24650444-BA1E2F4D-0D99-48BA-83BA-BDAAFCA2C3F9Q26751073-33483836-8617-45E1-AB3F-4C5D5EABC121Q27021700-F4C76F4D-D97B-40AA-9279-57A554B9CE75Q28259585-AC3B6D20-0E2C-43AA-99D8-11546584C2D9Q28388335-01BC74B5-5301-463C-AB4D-0A63AC3E6707Q31047131-1091DE78-AA23-412B-BC0C-8C01A03D1639Q33720596-D912B238-3CEF-4A20-89A1-D6B113373534Q33726019-DB4785C0-6835-4829-86B0-6D8F1523837FQ33740552-80AF3880-DFDC-47D7-8430-23EE5C008989Q33861622-0A6192DC-FF88-415F-86C1-438CF64BF8EBQ33957213-8FB5C88D-3BAE-4478-B504-E5E85A99C11BQ34066474-F2285803-16C7-4074-BB01-AA66875B431FQ34067084-F4B31D60-9F9A-4128-A147-BD490BDB6119Q34099450-3341DC2D-3E0F-47F5-900A-CEC99D02479BQ34766637-BA564B5B-4483-4883-B2C6-1097C0CCBA36Q35010262-8976A1A6-C989-4517-9E46-D59F4BE2568BQ35067441-7762D78D-C4E3-47CA-8DCF-51272869D708Q35226905-B0A2716D-9B4D-4E0D-A4AF-D01F9F2F1A0DQ35501612-CA74F0A0-D1F6-4CFC-8533-4BB26C70379CQ36822317-A3CAE98D-301C-452D-BC8D-0D85AE9C9CD5Q37195646-1E683464-4E99-4F33-BD4D-6913DD45D2B1Q37379834-8E9DE9B0-00A2-491D-AB96-09237E112FDEQ37428097-E5F008C2-C028-41F3-BB4F-CB7B95B57C31Q37641152-D5C50814-FEA2-46E1-942D-85BDF3AFE4A6Q37799838-8EC74CA4-360D-4B1C-8D73-FF1DB3C13DADQ37948993-2B1D07BF-B6E9-4DE7-BDA2-1E1EB6E947EDQ37996961-3F67AC4D-B378-4E62-9304-FFDC56A73068Q38029514-336AFCBD-7F4B-485A-8332-0BA9A858E3EAQ38130176-0BBEFCE4-0090-4755-9EFB-EF7458BC9F8AQ38176935-4D0430F5-C1D5-48FC-856A-D46579C25760Q38358865-C396385B-FC1D-4748-A0F7-34BA3B0303EEQ38897776-6E787801-4460-4B61-A899-5463A0535090Q39513747-BE5AB95C-EAA7-4B66-A6DA-1778483FB9FAQ39789745-179F70E3-3530-43CE-9E07-0C793C8112A2Q41989690-2FD23FED-32B9-480E-B9E6-AE8E27AA28D5Q46228001-CBA519E5-7FD9-45D8-91D4-0E3376B6E911Q47834807-2F2D3AD3-30A0-4316-8ACF-048E8CB978C6Q48400919-C9DE0DEC-D331-4F91-8760-5FE29DA29D16Q48419057-AE69F849-1339-4BA8-8469-D5A03AED42BEQ49058125-D7FCE46C-4BB7-48CE-B2F4-AA5EA6D889F7
P2860
Nanoparticle and other metal chelation therapeutics in Alzheimer disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Nanoparticle and other metal chelation therapeutics in Alzheimer disease.
@ast
Nanoparticle and other metal chelation therapeutics in Alzheimer disease.
@en
type
label
Nanoparticle and other metal chelation therapeutics in Alzheimer disease.
@ast
Nanoparticle and other metal chelation therapeutics in Alzheimer disease.
@en
prefLabel
Nanoparticle and other metal chelation therapeutics in Alzheimer disease.
@ast
Nanoparticle and other metal chelation therapeutics in Alzheimer disease.
@en
P2093
P50
P1476
Nanoparticle and other metal chelation therapeutics in Alzheimer disease.
@en
P2093
Matthew R Garrett
P304
P356
10.1016/J.BBADIS.2005.06.006
P407
P577
2005-09-01T00:00:00Z